ALETHIA BIOTHERAPEUTICS INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
C07K PEPTIDES 4132
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 3252

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0233,487 Anti-Clusterin Antibodies and Antigen Binding Fragments and their Use to Reduce Tumor VolumeNov 23, 16Aug 17, 17[C07K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9822170 Co-use of a clusterin inhibitor with an EGFR inhibitor to treat cancerFeb 22, 13Nov 21, 17[A61K, C07K]
9512211 Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volumeJun 23, 14Dec 06, 16[A61K, C07K]
8802826 Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volumeNov 24, 10Aug 12, 14[A61K, C07K]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
8444975 Method for inhibiting bone resorptionExpiredMay 23, 12May 21, 13[A61K]
2011/0293,604 POLYNUCLEOTIDES AND POLYPEPTIDE SEQUENCES INVOLVED IN THE PROCESS OF BONE REMODELINGAbandonedApr 07, 11Dec 01, 11[A61K, A61P]
2011/0286,924 NOVEL HUMAN ENDOGENOUS RETROVIRAL ERV3 VARIANT AND USES THEREOF IN THE DIAGNOSING OVARIAN CANCERAbandonedDec 23, 08Nov 24, 11[A61K, A61P, C07K]
7947436 Polynucleotides and polypeptide sequences involved in the process of bone remodelingExpiredDec 13, 05May 24, 11[G01N]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.